Concepedia
Statistics
Publications
11
Citations
1K
H-Index
10
Active since
1993
Affiliations
Covance (United States)(Current)
University of Washington
AstraZeneca (United States)
Pearson (United States)
Terry Podoll is an author at Covance (United States) specializing in drug discovery, pharmacology, and drug resistance.
Top concepts
MedicineBiochemistryPharmacologyDrug DiscoveryDrug ResistancePharmacotherapyNatural SciencesPharmacokineticsMedicinal ChemistryAntimicrobial Resistance
Publications per year
1993–2022
Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.
Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 356 citations
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.
Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 223 citations
IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES
Michael A. Wynalda, J. Matthew Hutzler, Michael D. Koets et al. · Drug Metabolism and Disposition · 2003 · 101 citations
Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.
Kenneth E. Thummel, Evan D. Kharasch, Terry Podoll et al. · Drug Metabolism and Disposition · 1993 · 87 citations
Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans
Terry Podoll, Paul G. Pearson, Jerry Evarts et al. · Drug Metabolism and Disposition · 2018 · 67 citations · Full text
1–5 of 11